Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Oxford University has recently led a successful bid to establish a €52M international consortium to develop induced pluripotent stem (iPS) cell lines for drug discovery and safety assessment.

Dopamine neurons (in green) grown using stem cell technology
Dopamine neurons (in green) grown using stem cell technology
Load More

Similar stories

Oxford-led cross-divisional collaboration wins the prestigious Cozzarelli Prize

A collaborative study between the Medical Sciences Division and the Mathematical, Physical and Life Sciences Division at the University of Oxford has been awarded the 2024 PNAS Cozzarelli Prize in Biomedical Science.